Learn how the FDA's 180-day exclusivity works for generic drug applicants, including Paragraph IV certifications, forfeiture risks, and upcoming regulatory changes.
Jul, 3 2026
Mar, 31 2026
May, 12 2026
Feb, 17 2026
Jan, 25 2026